Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Sinovac Acquires New Manufacturing Facility

publication date: Feb 15, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sinovac Biotech (北京科兴生物制品有限公司) has acquired a medical manufacturing site and land use rights in the Changping area of Beijing. The site, which includes five buildings previously used to produce medical products, is about a half-hour’s drive from Sinovac’s existing Beijing facility. Sinovac will pay 120 million RMB ($17.6 million), of which 56.5 million RMB ($8.3 million) is due before February 20, 2010 with the balance to be paid over three years. More details...

Stock symbols: (NSDQ: SVA)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners